Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Tech...

Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCs  Business Wire

Daiichi Sankyo Deepens Biologics Push As ENHERTU Faces FDA Decision - Yahoo Finance

Daiichi Sankyo Deepens Biologics Push As ENHERTU Faces FDA Decision  Yahoo Finance

How Sankyo Foods Is Taking Japanese Flavors Global, From Taberu Rayu to Toyohashi Chicken Curry -...

How Sankyo Foods Is Taking Japanese Flavors Global, From Taberu Rayu to Toyohashi Chicken Curry  The Worldfolio

Corporate Giving and Support - Daiichi Sankyo US

Corporate Giving and Support  Daiichi Sankyo US

Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know - TipRanks

Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know  TipRanks

Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance - F...

Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance  Fierce Pharma

Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncolo...

Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology  PR Newswire

Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline - BioSpace

Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline  BioSpace

Daiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued (OTCMKTS:DSNKY) - Seeking Alpha

Daiichi Sankyo: Hit On Multiple Fronts, But Shares Look Undervalued (OTCMKTS:DSNKY)  Seeking Alpha

Daiichi Sankyo gears up for five ADC launches in 2026 - pharmaphorum

Daiichi Sankyo gears up for five ADC launches in 2026  pharmaphorum

Japan expert panel OKs Daiichi Sankyo's MMR vaccine - The Japan Times

Japan expert panel OKs Daiichi Sankyo's MMR vaccine  The Japan Times

What is Daiichi Sankyo’s Post JP Morgan Strategy? - Pharmaceutical Executive

What is Daiichi Sankyo’s Post JP Morgan Strategy?  Pharmaceutical Executive

Is Now The Right Time To Reassess Daiichi Sankyo (TSE:4568) After Recent Share Price Weakness? - ...

Is Now The Right Time To Reassess Daiichi Sankyo (TSE:4568) After Recent Share Price Weakness?  Yahoo Finance

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Ther...

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.  Business Wire

HER2 in Gynecologic Cancers—Why It Matters - Daiichi Sankyo US

HER2 in Gynecologic Cancers—Why It Matters  Daiichi Sankyo US

Daiichi Sankyo tallies $1.9B in planned Enhertu manufacturing investments: Nikkei - Fierce Pharma

Daiichi Sankyo tallies $1.9B in planned Enhertu manufacturing investments: Nikkei  Fierce Pharma

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Tr...

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research  PR Newswire

Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologic...

Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms  Business Wire

Is It Time To Reconsider Daiichi Sankyo Company (TSE:4568) After Recent Share Price Weakness? - Y...

Is It Time To Reconsider Daiichi Sankyo Company (TSE:4568) After Recent Share Price Weakness?  Yahoo Finance

Daiichi Sankyo prevails on appeal in long-running ADC patent battle with Seagen, flipping prior $...

Daiichi Sankyo prevails on appeal in long-running ADC patent battle with Seagen, flipping prior $41.8M verdict  Fierce Pharma

AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer - BioSpace

AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer  BioSpace

Culture-Driven Talent Acquisition: How Daiichi Sankyo Builds Teams - Daiichi Sankyo US

Culture-Driven Talent Acquisition: How Daiichi Sankyo Builds Teams  Daiichi Sankyo US

How Daiichi Sankyo modernized drug discovery using AWS Parallel Computing Service | Amazon Web Se...

How Daiichi Sankyo modernized drug discovery using AWS Parallel Computing Service | Amazon Web Services  Amazon Web Services

Is Daiichi Sankyo Now an Opportunity After a 26% Share Price Slide? - Yahoo Finance

Is Daiichi Sankyo Now an Opportunity After a 26% Share Price Slide?  Yahoo Finance

The Bull Case For Daiichi Sankyo Company (TSE:4568) Could Change Following ENHERTU’s Priority Rev...

The Bull Case For Daiichi Sankyo Company (TSE:4568) Could Change Following ENHERTU’s Priority Review Success  simplywall.st

Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd - BioSpace

Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd  BioSpace

Lunit and Daiichi Sankyo Form Collaboration to Advance Research and Discovery for AI-Driven Bioma...

Lunit and Daiichi Sankyo Form Collaboration to Advance Research and Discovery for AI-Driven Biomarkers and Translational Oncology  Pharmaceutical Executive

General Proximity and Daiichi Sankyo collaborate on oncology - Pharmaceutical Technology

General Proximity and Daiichi Sankyo collaborate on oncology  Pharmaceutical Technology

Sankyo Foods’ Approach to Authentic Taste - The Worldfolio

Sankyo Foods’ Approach to Authentic Taste  The Worldfolio

Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Moat? - Yah...

Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Moat?  Yahoo Finance

Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFO - CNBC

Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFO  CNBC

Is Daiichi Sankyo (TSE:4568) Undervalued After Recent Share Price Weakness? A Fresh Look at Its 2...

Is Daiichi Sankyo (TSE:4568) Undervalued After Recent Share Price Weakness? A Fresh Look at Its 2028 Outlook  Yahoo Finance

Daiichi Sankyo launches its STING operation against cancer - pharmaphorum

Daiichi Sankyo launches its STING operation against cancer  pharmaphorum

Daiichi Sankyo (TSE:4568) Earnings Growth Slows to 11.8%, Testing Recent Bullish Narratives - Yah...

Daiichi Sankyo (TSE:4568) Earnings Growth Slows to 11.8%, Testing Recent Bullish Narratives  Yahoo Finance

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA - Business Wire

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA  Business Wire

BostonGene and Daiichi Sankyo to Bring AI Intel to ADC Development Program - Contract Pharma

BostonGene and Daiichi Sankyo to Bring AI Intel to ADC Development Program  Contract Pharma

General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advanc...

General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform  PR Newswire

Stock Pitch: Daiichi Sankyo (TSE: 4568) - Morningstar Canada

Stock Pitch: Daiichi Sankyo (TSE: 4568)  Morningstar Canada

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D - Yahoo Finance

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D  Yahoo Finance

BostonGene and Daiichi Sankyo Partner to Advance ADC Development with AI-Driven Multimodal Analyt...

BostonGene and Daiichi Sankyo Partner to Advance ADC Development with AI-Driven Multimodal Analytics  HLTH

Daiichi Sankyo Opens New Toronto HQ - Contract Pharma

Daiichi Sankyo Opens New Toronto HQ  Contract Pharma

Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next. - ...

Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.  BioPharma Dive

There May Be Underlying Issues With The Quality Of Daiichi Sankyo Company's (TSE:4568) Earnings -...

There May Be Underlying Issues With The Quality Of Daiichi Sankyo Company's (TSE:4568) Earnings  simplywall.st

Daiichi Sankyo picks Dr John Tsai to head up R&D - European Pharmaceutical Review

Daiichi Sankyo picks Dr John Tsai to head up R&D  European Pharmaceutical Review

SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Techn...

SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology  Business Wire

ESMO 2025: AstraZeneca and Daiichi Sankyo establish Enhertu in early breast cancer - Clinical Tri...

ESMO 2025: AstraZeneca and Daiichi Sankyo establish Enhertu in early breast cancer  Clinical Trials Arena

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lower...

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C  Business Wire

Daiichi Sankyo’s Dr Michael Zaiac on moving beyond ‘sick care’ - European Medical Journal

Daiichi Sankyo’s Dr Michael Zaiac on moving beyond ‘sick care’  European Medical Journal

BioMed X and Daiichi Sankyo Launch Immuno-Oncology Research Team - Contract Pharma

BioMed X and Daiichi Sankyo Launch Immuno-Oncology Research Team  Contract Pharma

Daiichi Sankyo Establishes Third Research Institute in San Diego - Yahoo Finance

Daiichi Sankyo Establishes Third Research Institute in San Diego  Yahoo Finance

Japan’s Daiichi Sankyo Shares Drop After Discounted Block Trades - Bloomberg.com

Japan’s Daiichi Sankyo Shares Drop After Discounted Block Trades  Bloomberg.com

What Recent Oncology Deal Means for Daiichi Sankyo Shares in 2025 - Yahoo Finance

What Recent Oncology Deal Means for Daiichi Sankyo Shares in 2025  Yahoo Finance

Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to A...

Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C  Business Wire

Earnings call transcript: Daiichi Sankyo Q3 2025 earnings beat expectations - Investing.com

Earnings call transcript: Daiichi Sankyo Q3 2025 earnings beat expectations  Investing.com

How Breakthrough ESMO 2025 Oncology Data at Daiichi Sankyo (TSE:4568) Has Changed Its Investment ...

How Breakthrough ESMO 2025 Oncology Data at Daiichi Sankyo (TSE:4568) Has Changed Its Investment Story  Yahoo Finance

Daiichi Sankyo Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For...

Daiichi Sankyo Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year  simplywall.st

AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics - Pharmafile

AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics  Pharmafile

Will Sankyo’s (TSE:6417) Anime Strategies Redefine Its Competitive Edge in the Gaming Market? - Y...

Will Sankyo’s (TSE:6417) Anime Strategies Redefine Its Competitive Edge in the Gaming Market?  Yahoo Finance

Daiichi Sankyo’s Breast Cancer Treatment, Enhertu, Approved in Japan - BioPharm International

Daiichi Sankyo’s Breast Cancer Treatment, Enhertu, Approved in Japan  BioPharm International

Japan's Daiichi Sankyo unveils new Toronto headquarters to accelerate investment and innovation i...

Japan's Daiichi Sankyo unveils new Toronto headquarters to accelerate investment and innovation in oncology  BioSpectrum Asia

Turning Complexity into Hope in Honor of My Father - Daiichi Sankyo US

Turning Complexity into Hope in Honor of My Father  Daiichi Sankyo US

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lower...

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C  BioSpace

Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe...

Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe  Yahoo Finance

Daiichi Sankyo (TSE:4568): Exploring Valuation as Investor Attention Grows - Yahoo Finance

Daiichi Sankyo (TSE:4568): Exploring Valuation as Investor Attention Grows  Yahoo Finance

Lunit, Daiichi Sankyo to partner on AI biomarker, oncology research - AuntMinnie

Lunit, Daiichi Sankyo to partner on AI biomarker, oncology research  AuntMinnie

Daiichi Sankyo: Pressing The ADC Case Further, Not Being Felt By The Market - Seeking Alpha

Daiichi Sankyo: Pressing The ADC Case Further, Not Being Felt By The Market  Seeking Alpha

BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development T...

BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics  Yahoo Finance

Open position: Nordic Sales Manager for Daiichi Sankyo Nordics - mva.org

Open position: Nordic Sales Manager for Daiichi Sankyo Nordics  mva.org

Daiichi Sankyo Announces Executive Changes - National Today

Daiichi Sankyo Announces Executive Changes  National Today

Immuto Scientific Announces $8M Seed 2 Financing and Daiichi Sankyo Collaboration to Uncover a Ne...

Immuto Scientific Announces $8M Seed 2 Financing and Daiichi Sankyo Collaboration to Uncover a New Class of Therapeutic Targets with Structural Surfaceomics  Business Wire

AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy ...

AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy  Yahoo Finance

Daiichi Sankyo is leveraging Azure OpenAI Service to develop generative AI and foster an AI-frien...

Daiichi Sankyo is leveraging Azure OpenAI Service to develop generative AI and foster an AI-friendly culture  Microsoft

Daiichi Sankyo (TSE:4568) Margin Improvement Supports Bullish Growth Narrative In Q3 2026 - simpl...

Daiichi Sankyo (TSE:4568) Margin Improvement Supports Bullish Growth Narrative In Q3 2026  simplywall.st

Daiichi Sankyo honored with Global Impact Award honorable mention by the HBA - PharmaLive

Daiichi Sankyo honored with Global Impact Award honorable mention by the HBA  PharmaLive

AstraZeneca, Daiichi Sankyo ADC Enhertu Moves Up to First-Line Use in Breast Cancer - MedCity News

AstraZeneca, Daiichi Sankyo ADC Enhertu Moves Up to First-Line Use in Breast Cancer  MedCity News

Daiichi Sankyo appoints new head for European research center - The Pharma Letter

Daiichi Sankyo appoints new head for European research center  The Pharma Letter

Japan's Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development - Bio...

Japan's Daiichi Sankyo collaborates with BostonGene to accelerate AI-based drug development  BioSpectrum Asia

Daiichi Sankyo has inventory buffer, will expand production capacity in Ohio to mitigate US tarif...

Daiichi Sankyo has inventory buffer, will expand production capacity in Ohio to mitigate US tariffs - CFO  CNBC

AAX Biotech Announces Collaboration with Daiichi Sankyo to Evaluate Opti-mAb® Technology in Next-...

AAX Biotech Announces Collaboration with Daiichi Sankyo to Evaluate Opti-mAb® Technology in Next-Generation Antibody Therapeutics  Cision News

Earnings call transcript: Daiichi Sankyo Q2 2025 misses EPS forecast, stock drops - Investing.com

Earnings call transcript: Daiichi Sankyo Q2 2025 misses EPS forecast, stock drops  Investing.com

Daiichi Sankyo's World-Leading Antibody Drug Conjugate Platform Continues to Make Progress - Morn...

Daiichi Sankyo's World-Leading Antibody Drug Conjugate Platform Continues to Make Progress  Morningstar

FDA to priority-review Daiichi Sankyo and AZ’s Enhertu sBLA - Yahoo Finance

FDA to priority-review Daiichi Sankyo and AZ’s Enhertu sBLA  Yahoo Finance

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients ...

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy  Business Wire

Japanese Drugmaker Daiichi Sankyo Breaks Ground on USD154 Million ADC Facility in Shanghai - Yica...

Japanese Drugmaker Daiichi Sankyo Breaks Ground on USD154 Million ADC Facility in Shanghai  Yicai Global

AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data - BioSpace

AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data  BioSpace

Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen - Endpoints News

Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen  Endpoints News

Wayfinder Biosciences and Daiichi Sankyo collaborate to develop novel RNA-targeting therapies for...

Wayfinder Biosciences and Daiichi Sankyo collaborate to develop novel RNA-targeting therapies for neurodegenerative disease  PR Newswire

China to Keep Driving Pharma Industry Transformation, Daiichi Sankyo's China Head Says - Yicai Gl...

China to Keep Driving Pharma Industry Transformation, Daiichi Sankyo's China Head Says  Yicai Global

Daiichi Sankyo celebrates its roots and blooming future at DC cherry blossom festival - Fierce Ph...

Daiichi Sankyo celebrates its roots and blooming future at DC cherry blossom festival  Fierce Pharma

Daiichi Sankyo and MSD withdraw US BLA for lung cancer treatment - Yahoo Finance

Daiichi Sankyo and MSD withdraw US BLA for lung cancer treatment  Yahoo Finance

Daiichi Sankyo connects cherry blossom trees to future of oncology pipeline - Medical Marketing a...

Daiichi Sankyo connects cherry blossom trees to future of oncology pipeline  Medical Marketing and Media

AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in U...

AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in US  Yahoo Finance UK

Approaching the business with a 'patient-centric mindset': Daiichi Sankyo CEO - CNBC

Approaching the business with a 'patient-centric mindset': Daiichi Sankyo CEO  CNBC

Let Me Tell You About My Aunt Maryann - Daiichi Sankyo US

Let Me Tell You About My Aunt Maryann  Daiichi Sankyo US

Daiichi Sankyo at ASCO 2025: Markus Kosch on Advancing Patient Outcomes Through Scientific Innova...

Daiichi Sankyo at ASCO 2025: Markus Kosch on Advancing Patient Outcomes Through Scientific Innovation  Oncodaily

Daiichi Sankyo breaks ground on $151M cancer drug plant in Shanghai - China.org.cn

Daiichi Sankyo breaks ground on $151M cancer drug plant in Shanghai  China.org.cn

Daiichi Sankyo: Driving growth through innovation in healthcare - Politics UK

Daiichi Sankyo: Driving growth through innovation in healthcare  Politics UK

AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line Breast Cancer Therapy - ...

AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line Breast Cancer Therapy  MedCity News

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Ther...

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.  Via Ritzau

TROPION-SWISH: New Phase IV Study Targets Side-Effect Risk in AstraZeneca and Daiichi Sankyo’s Da...

TROPION-SWISH: New Phase IV Study Targets Side-Effect Risk in AstraZeneca and Daiichi Sankyo’s Dato-DXd  TipRanks